查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2019788

血液输注诊断市场规模、份额、成长及全球产业分析：按类型和应用、区域洞察及2026-2034年预测

Blood Transfusion Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 190 Pages | 商品交期: 请询问到货日

价格

血液输注诊断市场的成长要素

受对更安全输血流程的需求不断增长以及血液相关疾病发病率上升的推动，全球输血诊断市场正经历强劲增长。预计该市场规模将在2025年达到57亿美元，2026年达到61.2亿美元，并在2034年进一步扩大至112.5亿美元。此稳定成长在预测期内的复合年增长率（CAGR）为7.90%。 2025年，北美将以39.71%的市占率引领市场，这得益于其先进的医疗基础设施和高度的血液安全意识。

输血诊断是指输血前对血液样本进行的一系列检测，以确认供血者和受血者的血型是否相容，并预防感染疾病的传播。这些检测包括血型鑑定、抗体筛检和输血传染性行为感染（TTI）的检测。由于输血疗法在外科手术、创伤治疗和慢性病管理中发挥着至关重要的作用，因此，准确的诊断程序在全球范围内的重要性日益凸显。

市场趋势

推动市场发展的关键趋势之一是转型为自动化和分子诊断平台。自动化显着提高了血液检测流程的准确性、速度和效率。核酸检测 (NAT) 和 DG 凝胶系统等技术正日益广泛地应用，以最大限度地减少人为误差并提高可靠性。这些创新使检查室和血库能够简化操作流程、提高病患安全，并最终推动市场成长。

市场成长要素

对血液及血液成分日益增长的需求是市场扩张的主要驱动力。贫血、癌症和肾臟病等慢性疾病的盛行率不断上升，显着增加了定期输血的需求。此外，外科手术、创伤病例和分娩併发症的增加也进一步推动了血液诊断的需求。

另一个重要的成长要素是人们对血液安全的日益重视。各国政府、医疗机构和非政府组织都在积极推广安全的捐血规范和筛检程序。这促使医院、检查室和血库采用先进的诊断工具，进而支持市场成长。

抑制因子

儘管市场成长前景强劲，但也面临一些挑战。诊断设备和检测套组的高成本是一大障碍，尤其是在发展中地区。此外，医疗基础设施和专业人员的匮乏也阻碍了先进诊断技术的应用。这些因素限制了医疗投资相对较低的新兴国家的市场成长。

細項分析

按产品类型划分，试剂和试剂盒由于在血液筛检和血型鑑定程序中反覆使用而占据市场主导地位，预计到 2026 年将占据 79.46% 的市场份额。设备部分由于成本高、使用寿命长，市占率较小。

按应用领域划分，预计到2026年，血液筛检领域将以69.06%的市场份额引领市场，这主要得益于捐血中感染疾病检测需求的不断增长。血型鑑定业务也在稳定成长，这主要受血型相容性检测需求增加的推动。

就最终用户而言，预计到 2026 年，全球处理大量血液检测的独立实验室和血库将主导市场，占总市场份额的 60.89%。

区域趋势

北美仍然是一个主要地区，预计到 2025 年市场规模将达到 22.6 亿美元，到 2026 年将达到 24.2 亿美元。这得益于其健全的医疗保健系统和较高的输血率。

在先进的诊断技术和监管支援的推动下，预计到 2025 年欧洲市场规模将达到 16.1 亿美元，到 2026 年将成长至 17.3 亿美元。

预计亚太地区在 2025 年将达到 13.1 亿美元，在 2026 年将达到 14.3 亿美元，成长速度最快，这主要得益于人口成长、医疗保健投资增加和宣传活动的开展。

拉丁美洲、中东和非洲地区正经历温和成长，这得益于医疗保健服务的改善和尚未开发的市场机会。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 2025年主要国家捐血统计数据
  • 新冠疫情对市场的影响
  • 2025年主要地区和国家主要出血性疾病盛行率
  • 中国捐血血型分布
  • 印度和美国人口血型分布情况
  • 2025年输血统计数据
  • 产业重大发展动态－合併、收购、合作等。

第五章：2021-2034年全球输血诊断市场分析、洞察与预测

  • 市场分析、洞察与预测：按产品划分。
    • 装置
    • 试剂和试剂盒
  • 市场分析、洞察与预测：按应用领域划分
    • 血液筛检
    • 血型测定
  • 市场分析、洞察与预测：按最终用户划分
    • 医院检查室
    • 独立检测实验室和血库
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美输血诊断市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲输血诊断市场分析、洞察与预测（2021-2034年）

  • 国家
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪地那维亚
    • 其他欧洲国家

第八章：亚太地区输血诊断市场分析、洞察与预测（2021-2034年）

  • 国家
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 其他亚太国家

第九章：拉丁美洲输血诊断市场分析、洞察与预测（2021-2034年）

  • 国家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东和非洲输血诊断市场分析、洞察与预测（2021-2034年）

  • 国家
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲国家

第十一章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • Abbott
    • F. Hoffmann-La Roche AG
    • Grifols, SA
    • Immucor, Inc.
    • Bio-Rad Laboratories, Inc.
    • Ortho Clinical Diagnostics
    • QUOTIENT
    • Merck KGaA
Product Code: FBI100596

Growth Factors of blood transfusion diagnostics Market

The global blood transfusion diagnostics market is witnessing strong growth due to the rising demand for safe blood transfusion procedures and increasing prevalence of blood-related disorders. The market was valued at USD 5.70 billion in 2025 and is projected to reach USD 6.12 billion in 2026, further expanding to USD 11.25 billion by 2034. This steady growth reflects a CAGR of 7.90% during the forecast period. In 2025, North America dominated the market with a 39.71% share, driven by advanced healthcare infrastructure and high awareness of blood safety.

Blood transfusion diagnostics refers to a range of tests conducted on blood samples before transfusion to ensure compatibility between donor and recipient and to prevent the transmission of infectious diseases. These tests include blood grouping, antibody screening, and detection of transfusion-transmissible infections (TTIs). As transfusion therapy plays a vital role in surgeries, trauma care, and chronic disease management, the importance of accurate diagnostic procedures continues to grow globally.

Market Trends

One of the major trends shaping the market is the shift toward automated and molecular diagnostic platforms. Automation has significantly improved the accuracy, speed, and efficiency of blood testing processes. Technologies such as nucleic acid testing (NAT) and DG gel systems are increasingly being adopted to minimize human error and enhance reliability. These innovations allow laboratories and blood banks to streamline operations and improve patient safety, thereby boosting market growth.

Market Growth Drivers

The increasing demand for blood and blood components is a key factor driving market expansion. The rising prevalence of chronic diseases such as anemia, cancer, and kidney disorders has significantly increased the need for regular blood transfusions. Additionally, the growing number of surgical procedures, trauma cases, and childbirth-related complications further fuels the demand for blood diagnostics.

Another important growth factor is the rising awareness regarding blood safety. Governments, healthcare organizations, and NGOs are actively promoting safe blood donation practices and screening protocols. This has led to increased adoption of advanced diagnostic tools across hospitals, laboratories, and blood banks, thereby supporting market growth.

Restraining Factors

Despite strong growth prospects, the market faces certain challenges. The high cost of diagnostic instruments and testing kits is a major barrier, especially in developing regions. Additionally, limited healthcare infrastructure and a shortage of skilled professionals hinder the adoption of advanced diagnostic technologies. These factors restrict market growth in emerging economies where healthcare investments are comparatively low.

Segmentation Analysis

By product type, the reagents and kits segment dominates the market, accounting for 79.46% share in 2026, due to their recurring use in blood screening and typing procedures. The instruments segment holds a smaller share due to higher costs and longer lifecycle.

Based on application, the blood screening segment leads the market with a 69.06% share in 2026, driven by the increasing need to detect infectious diseases in donated blood. Blood group typing is also growing steadily due to rising demand for compatibility testing.

By end-user, independent laboratories and blood banks dominate with a 60.89% share in 2026, as they handle a large volume of blood testing procedures globally.

Regional Insights

North America remains the leading region, valued at USD 2.26 billion in 2025 and projected to reach USD 2.42 billion in 2026, supported by strong healthcare systems and high transfusion rates.

Europe held USD 1.61 billion in 2025, growing to USD 1.73 billion in 2026, driven by advanced diagnostic technologies and regulatory support.

Asia Pacific accounted for USD 1.31 billion in 2025 and is expected to reach USD 1.43 billion in 2026, witnessing the fastest growth due to rising population, increasing healthcare investments, and awareness programs.

Latin America and the Middle East & Africa show moderate growth, supported by improving healthcare access and untapped market opportunities.

Competitive Landscape

The market is highly competitive with key players such as Immucor, Inc., Grifols, S.A., Ortho Clinical Diagnostics, Abbott Laboratories, and F. Hoffmann-La Roche Ltd. These companies focus on product innovation, strong distribution networks, and strategic collaborations to strengthen their market presence.

Conclusion

In conclusion, the blood transfusion diagnostics market is set for substantial growth from USD 5.70 billion in 2025 to USD 11.25 billion by 2034, driven by rising healthcare needs, technological advancements, and increasing awareness of blood safety. While high costs and infrastructure limitations pose challenges, ongoing innovations and global health initiatives are expected to overcome these barriers. The market will continue to play a critical role in ensuring safe and efficient transfusion practices worldwide.

Growth Rate CAGR of 7.90% from 2026-2034

Segmentation By Product

  • Instruments
  • Kits & Reagents

By Application

  • Blood Screening
  • Blood Group Typing

By End-user

  • Hospital-based Laboratories
  • Independent Laboratories & Blood Banks

By Geography

  • North America (By Product, By Application, By End-user, and By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product, By Application, By End-user, and By Country/ Sub-region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product, By Application, By End-user, and By Country/ Sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Product, By Application, By End-user, and By Country/ Sub-region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Product, By Application, By End-user, and By Country/ Sub-region)
    • GCC (By Application)
    • South Africa (By Application)
  • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Blood Donations Statistics, By Key Countries, 2025
  • 4.2. Impact of COVID-19 on the Market
  • 4.3. Prevalence of Key Bleeding Disorders, Key Regions/ Country, 2025
  • 4.4. Blood Group Distribution Among Blood Donors in China
  • 4.5. Distribution of Blood Group Type Among Indian & the U.S. Population
  • 4.6. Blood Transfusion Statistics, 2025
  • 4.7. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.

5. Global Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Kits
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Blood Screening
    • 5.2.2. Blood Group Typing
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospital-based Laboratories
    • 5.3.2. Independent Laboratories & Blood Banks
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Kits
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Blood Screening
    • 6.2.2. Blood Group Typing
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospital-based Laboratories
    • 6.3.2. Independent Laboratories & Blood Banks
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Kits
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Blood Screening
    • 7.2.2. Blood Group Typing
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospital-based Laboratories
    • 7.3.2. Independent Laboratories & Blood Banks
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Application
    • 7.4.2. Germany
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Spain
      • 7.4.4.1. By Application
    • 7.4.5. Italy
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Kits
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Blood Screening
    • 8.2.2. Blood Group Typing
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospital-based Laboratories
    • 8.3.2. Independent Laboratories & Blood Banks
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Application
    • 8.4.2. China
      • 8.4.2.1. By Application
    • 8.4.3. India
      • 8.4.3.1. By Application
    • 8.4.4. Australia
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Kits
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Blood Screening
    • 9.2.2. Blood Group Typing
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospital-based Laboratories
    • 9.3.2. Independent Laboratories & Blood Banks
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Instruments
    • 10.1.2. Reagents & Kits
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Blood Screening
    • 10.2.2. Blood Group Typing
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospital-based Laboratories
    • 10.3.2. Independent Laboratories & Blood Banks
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC Countries
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Abbott
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. F. Hoffmann-La Roche AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Grifols, S.A.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Immucor, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Bio-Rad Laboratories, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Ortho Clinical Diagnostics
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. QUOTIENT
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Merck KGaA
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 4: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 6: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: U.S. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 10: Canada Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 14: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 15: U.K. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 16: Germany Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 17: France Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 18: Italy Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Spain Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Scandinavia Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 21: Rest of Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 23: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 24: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Japan Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: China Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 28: India Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Australia Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 30: Rest of Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 32: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 33: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 34: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 35: Brazil Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 36: Mexico Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 37: Rest of Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 39: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 40: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 41: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 42: GCC Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 43: South Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 44: Rest of Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 1: Global Blood Transfusion Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Blood Transfusion Diagnostics Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 8: North America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 10: North America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 12: North America Blood Transfusion Diagnostics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Blood Transfusion Diagnostics Market Value Share (%), By Country, 2025
  • Figure 14: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 16: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 18: Europe Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 32: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 40: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Blood Transfusion Diagnostics Market Share (%), By Company, 2025